Phaarmasia Limited (BOM:523620)

Market Cap	523.15M +190.3%
Revenue (ttm)	486.03M +111.8%
Net Income	176.42M
EPS	25.82
Shares Out	6.83M
PE Ratio	2.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	193
Open	76.63
Previous Close	77.01
Day's Range	72.10 - 76.63
52-Week Range	26.66 - 131.75
Beta	0.79
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Phaarmasia

Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India. It offers hormone products, including mifepristone and misoprostaol, desogestrel and ethinyl estradiol, estradiol valerate, levonorgestrel and ethinyl estradiol, medroxyprogesterone acetate, cabergoline, clomiphene citrate, levonorgestrel, progesterone, fluoxymesterone, liothyronine sodium, chlorodehydromethyltestosterone, liothyronine sodium, oxandrolone tablets, testosterone cypionate, methenolone enanthate, drostanolone, testosterone, trenbolone, an...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 36
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 523620

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 18, 2026

Data Sources Report a data error